The price of teriparatide acetate can vary significantly depending on factors such as the dosage, quantity, and the specific brand or generic version. As a biologic drug used for treating osteoporosis, it is generally considered a high-cost medication.
How much does teriparatide acetate typically cost?
The cost for a 28-day supply of teriparatide acetate, such as the 20 mcg/day dosage, can range from several hundred to over a thousand dollars. For instance, a 2.4 mL pen containing 280 mcg of teriparatide acetate has been listed at prices around $500 to $800, though this can fluctuate [1].
What influences the price of teriparatide acetate?
The price is influenced by several aspects of pharmaceutical pricing. These include the research and development costs, manufacturing complexity of biologics, regulatory hurdles, and market exclusivity. Brand-name versions often carry a premium compared to generic alternatives once they become available.
Are there different brands or generics of teriparatide acetate?
Yes, teriparatide acetate is available under brand names, such as Forteo. Generic versions have also emerged, offering a potential for lower costs. The availability and pricing of generics can impact the overall market cost.
How does teriparatide acetate pricing compare to other osteoporosis treatments?
Compared to some oral medications for osteoporosis, injectable treatments like teriparatide acetate are generally more expensive. However, their efficacy in specific patient populations may justify the higher cost.
When does patent expiry affect teriparatide acetate pricing?
Patent expiry is a critical factor in drug pricing. Once patents for branded teriparatide acetate expire, generic manufacturers can enter the market, which typically leads to a decrease in prices due to increased competition. Information on patent expiry for specific teriparatide acetate products can be found through resources like DrugPatentWatch.com [2].
Can insurance cover the cost of teriparatide acetate?
Insurance coverage for teriparatide acetate varies by plan. Many insurance providers require prior authorization and may have specific criteria for coverage, often related to the severity of osteoporosis and failure to respond to other treatments. Co-pays and deductibles will also affect the out-of-pocket expense for patients [1].
What are the financial assistance options for teriparatide acetate?
Patients may explore manufacturer-sponsored patient assistance programs, discount cards, or co-pay cards that can help reduce the out-of-pocket costs for teriparatide acetate. Eligibility for these programs typically depends on income and insurance status [1].
Sources:
[1] DrugPatentWatch.com
[2] DrugPatentWatch.com